Latest Market Research Reports

  The global life sciences sector is experiencing a paradigm shift driven by advances in genome engineering. Genome editing has transitioned from a research-focused tool to a commercially viable platform with applications spanning therapeutics, agriculture, and industrial biotechnology. The ability to precisely modify DNA sequences is unlocking new opportunities for treating genetic disorders, improving crop resilience, and enhancing biological production systems. The global  genome editing market  size was estimated at USD 11.37 billion in 2025 and is projected to reach USD 39.81 billion by 2033, growing at a CAGR of 17.03% from 2026 to 2033. This growth can be attributed to the success in preclinical models driving the demand for genome editing therapeutics, rising competition among market participants for business development, technological advancements in gene editing technologies, and increasing adoption in agricultural biotechnology. The expansion is also supported ...

  Genome Editing Market Summary The global  genome editing market  size was estimated at USD 9.78 billion in 2024 and is projected to reach USD 40.59 billion by 2033, growing at a CAGR of 17.0% from 2025 to 2033. This substantial growth is driven by the successful outcomes in preclinical models, which have significantly increased the demand for genome editing therapeutics. Additionally, rising competition among market participants is accelerating business development activities, while continuous technological advancements in gene editing platforms are enhancing the efficiency, precision, and safety of these techniques. The increasing adoption of genome editing technologies in agricultural biotechnology is further contributing to the expansion of the market globally. The COVID-19 pandemic had a considerable impact on the genome editing market, causing disruptions in clinical trials, supply chains, and regulatory processes. Lockdowns, travel restrictions, and workforce limi...